Private equity firm LBO France has signed an agreement with Vivo Capital, a healthcare and life science-focused investment firm, for the sale of European consumables and equipment distribution firm Dutscher Group.
Following a successful consultation process, Dutscher’s employee representative bodies have rendered a favourable opinion on the transaction, which is expected to close during the first half of 2026, subject to regulatory approvals. The deal is Vivo Capital’s first buyout investment in Europe.
Founded in 1982 and based in Brumath, near Strasbourg, Dutscher generated revenues exceeding €400m in 2025, representing an average organic growth of 7% per year. It employs over 1,100 people, with over 50% of its revenues originating outside France. Consumable products drive a large share of its revenues. It oversees more than 1 million stock-keeping units and a client base of more than 25,000 customers.
Under the ownership of LBO France, which acquired the group in 2020, Dutscher made 13 acquisitions, notably in France, the United Kingdom, Ireland, Scandinavia, and the Baltic States. This was accompanied by structural investments, including the construction of three new warehouses in France, the United Kingdom, and Spain.
Through capital and strategic capabilities, LBO France says it has supported Dutscher’s management in modernising operations and expanding into high-potential market segments, particularly cleanrooms, chemistry, agri-food, and commercial sectors.
